This aligns with the charging capabilities of Vivo’s recently launched X200 series, suggesting the S20 Pro might offer similarly speedy top-ups. Finally, the leak mentions a “thin body” for ...

The iQOO 13 flagship is official, and now we learned the vivo brand is preparing another ... The leak also revealed a bigger battery with faster charging rates and a new camera sensor on the ...

Vivo iQOO 13 is designed to deliver high performance ... The phone’s large 6150mAh battery supports 120W FlashCharge technology, which can charge the device from empty to full in just 19 minutes.

Vivo has introduced its new mid-range smartphone, the Vivo Y300 Plus, in India, featuring a Snapdragon 695 chipset, a 5000 mAh battery, and dual rear cameras. Priced at Rs 23,999, it boasts a 6.78 ...

Powered by the MediaTek Dimensity 7300 SoC, the Vivo V40e packs a 5,500 mAh battery with 80W wired fast charging support. For imaging, there is a 50MP dual rear camera setup and a 50MP Samsung JN1 ...

The Vivo Y300 Plus is equipped with a 6.78-inch ... Moreover, the device packs a 5000mAh battery that supports 44W fast charging for quick power-ups. The phone also includes multiple connectivity ...

Other highlights of the vivo Y300 Plus include Android 14-based Funtouch OS 14, IP54 rating, 5,000 mAh battery, and 44W charging. The vivo Y300 Plus is offered in Silk Black and Silk Green colors ...

The powerful 3nm Dimensity 9400 chipset and advanced imaging capabilities position Vivo as a major player in the high-end smartphone market. Credit: Vivo Every Wednesday and Friday, TechNode’s ...

Meanwhile, a Vivo smartphone with model number V2429A has been spotted on the 3C certification website. This gives information about the phone’s charging capacity. A few days ago, this Vivo phone was ...

INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target CD20-expressing malignant B cells Interim ...

(MENAFN- GlobeNewsWire - Nasdaq) INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient's body to target CD20-expressing ...